DE832045C - Means to prevent conception - Google Patents

Means to prevent conception

Info

Publication number
DE832045C
DE832045C DEP47770A DEP0047770A DE832045C DE 832045 C DE832045 C DE 832045C DE P47770 A DEP47770 A DE P47770A DE P0047770 A DEP0047770 A DE P0047770A DE 832045 C DE832045 C DE 832045C
Authority
DE
Germany
Prior art keywords
anticoncipient
salts
prevent conception
sulfonic acid
oxyquinoline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DEP47770A
Other languages
German (de)
Inventor
Dr Med Wilhelm Lehnert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
WILHELM LEHNERT DR MED
Original Assignee
WILHELM LEHNERT DR MED
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by WILHELM LEHNERT DR MED filed Critical WILHELM LEHNERT DR MED
Priority to DEP47770A priority Critical patent/DE832045C/en
Application granted granted Critical
Publication of DE832045C publication Critical patent/DE832045C/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
    • A01N43/40—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
    • A01N43/42—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings condensed with carbocyclic rings

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Agronomy & Crop Science (AREA)
  • Biomedical Technology (AREA)
  • Reproductive Health (AREA)
  • Toxicology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

Mittel zur Verhütung der Empfängnis Die Zusammensetzung des Anticoncipiens ist folgende: o,iog Salze der o-Oxychinolitisulfonsäure, o,12 g Gelatine, o,4o g Aqua dest., i,2o g Glycerin.Means for preventing conception The composition of the anticoncipient is as follows: o, iog salts of o-oxyquinolite sulfonic acid, o, 12 g gelatin, o, 4o g Aqua dest., 1.2 g glycerine.

Das Verfahren zur Herstellung des Anticoncipiens ist folgendes: i. Die gesamte Nletige von Gelatine wird in Aqua dest. geweicht, sodann durch Pressen wieder von Aqua dest. frei gemacht; 2. die Salze der o-Oxychinolinsulfonsäurewerden in einem Teil Aqua dest. zur vollständigen Auflösung gebracht; 3. die drei anderen Substanzen, Aqua dest., Glycerin und Gelatine, werden in einem Gefäß bei mindestens 6o°, höchstens 70° Wasserbadtemperatur zur vollständigen Auflösung und Emulgierung gebracht; die aufgelösten Salze der o-Oxychinolinsulfonsäure werden der aufgelösten emulgierten Substanz hinzugefügt; 5. nach einer vollständigen Vermengung des Ganzen wird alsdann bei 6o° Temperatur das Gießen der Kugeln in besonders angefertigten Gußformen mit besonderer Legierung vorgenommen; 6. nach dem Gießen muß die Form sofort stark abgekühlt werden, um die Entnahme des fertigen Präparates zu ermöglichen; 7. das gleiche Verfahren ist anzuwenden bei Herstellung des Anticoncipiens in Zäpfchenform. Vorteile: Die Vorteile gegenüber anderen Präparaten bestehen in der einfachen Anwendung, der größtmöglichen Sicherheit und absoluten Unschädlichkeit sowie in der wohltuenden Wirkung auf die betreffenden Organe.The procedure for making the anticoncipient is as follows: i. All of the gelatine needs to be dissolved in distilled water. softened, then by pressing again from Aqua dest. made free; 2. the salts of o-oxyquinoline sulfonic acid become in one part Aqua dest. brought to full dissolution; 3. the other three Substances, aqua dest., Glycerin and gelatin, are in a vessel at at least 60 °, maximum 70 ° water bath temperature for complete dissolution and emulsification brought; the dissolved salts of o-oxyquinoline sulfonic acid are dissolved emulsified substance added; 5. after a complete blending of the whole The balls are then poured into a custom-made at a temperature of 60 ° Molds made with a special alloy; 6. After casting, the mold must be be cooled down immediately to enable the finished preparation to be removed; 7. The same procedure is to be used for the production of the anticoncipient in suppository form. Advantages: The advantages over other preparations are the ease of use, the largest possible Security and absolute harmlessness as well in the beneficial effect on the organs concerned.

Das Präparat zerstört in kürzester Zeit CQlibazillen, Staphylokökken und Spermatozoen, ohne die Döderleinsche Milchsäurebazillenflora der Vagina zu beeinträchtigen.The preparation destroys CQlibacilli and Staphylococci in a very short time and spermatozoa without affecting the Döderlein lactic acid bacilli flora of the vagina.

Das Anticoncipiens behebt zugleich übelriechende Sekretionen. Der sich bei der Einführung des Anticoncipiens bildende Film gewährleistet eine mehrstündige Empfängnisverhütung.The Anticoncipiens at the same time removes bad-smelling secretions. Of the The film that forms at the time of the introduction of the anticoncipient guarantees a several-hour period Contraception.

Das Anticoncipiens hat die zusätzliche Wirkung, daß eine Vaginalkugel, in abgekochtem warmem Wasser aufgelöst, zu angenehm wirkenden Spülungen und Waschungen verwendet werden kann.The anticoncipient has the additional effect that a vaginal ball, Dissolve in boiled, warm water for pleasant rinses and washes can be used.

Claims (1)

PATENTANSPRUCH: Mittel- zur Verhütung der Empfängnis in Form von Kugeln oder Zäpfchen, bestehend aus Salzen der o-Oxychinolinsulfonsäure, Glycerin und Gelatine. Angezogene Druckschriften: Gehes Codex i937, S. 330, i2.12, i478, i326 und 1687; Hagers Handbuch der Pharmazeutischen Praxis 1927, Bd. 11. S. 824, Abs. .1.PATENT CLAIM: Means for preventing conception in the form of balls or suppositories, consisting of salts of o-oxyquinoline sulfonic acid, glycerine and gelatin. Cited pamphlets: Gehes Codex 1937, p. 33 0 , i2.12, i478, i326 and 1687; Hager's Handbook of Pharmaceutical Practice 1927, Vol. 11. S. 824, Paragraph .1.
DEP47770A 1949-07-05 1949-07-05 Means to prevent conception Expired DE832045C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DEP47770A DE832045C (en) 1949-07-05 1949-07-05 Means to prevent conception

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEP47770A DE832045C (en) 1949-07-05 1949-07-05 Means to prevent conception

Publications (1)

Publication Number Publication Date
DE832045C true DE832045C (en) 1952-02-21

Family

ID=7382635

Family Applications (1)

Application Number Title Priority Date Filing Date
DEP47770A Expired DE832045C (en) 1949-07-05 1949-07-05 Means to prevent conception

Country Status (1)

Country Link
DE (1) DE832045C (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0298527A1 (en) * 1987-05-14 1989-01-11 Fundatech S.A. Contraceptive suppository based on gelatine, and process for its manufacture

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
None *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0298527A1 (en) * 1987-05-14 1989-01-11 Fundatech S.A. Contraceptive suppository based on gelatine, and process for its manufacture

Similar Documents

Publication Publication Date Title
Crary et al. Modified benzyl alcohol clearing of alizarin-stained specimens without loss of flexibility
Vandenbergh Hormonal basis of sex skin in male rhesus monkeys
US3122475A (en) Circulatory adjuvant shell elements for cardiac glycoside suppository cores
DE832045C (en) Means to prevent conception
Mills The treatment of idiopathic (hypochromic) anaemia with iron and copper
US2203436A (en) Masticatory
DEP0047770DA (en) Means for preventing conception
EP0121543B1 (en) Contraceptive vaginal tablets and manufacturing method thereof
CN113081933A (en) Acne-removing composition and preparation method and application thereof
DE2331456A1 (en) Orally administered hair-care agents - including aneurin, calcium D-pantothenate, Vigar yeast, L-cystine and keratin
CN110368453A (en) A kind of anti-acne thermo-sensitive gel and preparation method thereof
CN1054980C (en) Painless induced labor liquor
DE2351512A1 (en) Soln contg sulphamethazine, aspartic acid, etc for burn therapy - increases blood flow and aids growth of new skin
DE874061C (en) Process for the production of a blood-coagulant substance from the lungs
Savill Cauterization of the Cervix
Levitt Temporary Sterilization by X Rays
Fisher Contraceptives and Fertility
Fairhurst et al. Ventricular tachycardia associated with thyrotoxicosis
AT212975B (en) Process for the production of organ preparations preserved by freeze-drying with increased physiological effectiveness
DE3806098A1 (en) Procamillan
DYES THE occurrence of dermatoses following the use of dyes is well known. In January 1932 we drew tt
Greenhill Induction of abortion by means of intrauterine application of a paste: Wolf, H.: Monatschr. f. Geburtsh. u. Gynäk. 88: 442, 1931
STEWARDSON ART. IV.--Remarks upon the cases of Smallpox admittled into the City Hospital during the years 1840, 41, and 42.--
Mackenzie Remarks on Various Diseases of the Skin
Zahl A Simple Method for Extirpating an Experimental Tumor